Orange Book product · Brand (NDA)
LITHONATE
LITHIUM CARBONATE
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
LITHIUM CARBONATE
Strength
300MG
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
NDA 016782
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 1987LITHIUM CARBONATEBrand (NDA)
NDA 017812 · HIKMA
- 1985LITHANEBrand (NDA)
NDA 018833 · BAYER PHARMS
- 1982ESKALITH CRBrand (NDA)
NDA 018152 · JDS PHARMS
- 1982LITHIUM CARBONATEBrand (NDA)
NDA 018558 · HIKMA
- —ESKALITHBrand (NDA)
NDA 016860 · NOVEN THERAP
- —LITHOBIDBrand (NDA)
NDA 018027 · ANI PHARMS
- —ESKALITHBrand (NDA)
NDA 017971 · JDS PHARMS
- —LITHIUM CARBONATEBrand (NDA)
NDA 016834 · PFIZER
- —LITHOTABSBrand (NDA)
NDA 016980 · SOLVAY
- 2017LITHIUM CARBONATEGeneric (ANDA)
ANDA 205663 · UNIQUE
- 2016LITHIUM CARBONATEGeneric (ANDA)
ANDA 205532 · HERITAGE PHARMA
- 2015LITHIUM CARBONATEGeneric (ANDA)
ANDA 204779 · UNIQUE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
